Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 87

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 87
---
 which means that we can disclose important information to you by referring you to those documents that are considered part of this prospectus. Information that we file subsequently with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below, and any documents that we file with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus until the offering of all of the securities covered by a particular prospectus supplement has been terminated or completed (excluding any portions of such documents that have been “furnished” but not “filed” for purposes of the Exchange Act):

•

our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed on February 18, 2025, which we refer to as our 2024 Form 10-K;

•

our Current Reports on Form 8-K filed on January 16, 2025and February 12, 2025; and

•

portions of our Proxy Statement on Schedule 14A, filed on March 20, 2024, that are incorporated by reference into Part III of our Form 10-K for the fiscal year ended December 31, 2023, filed on February 20, 2024, as amended by Amendment No. 1 to the Form 10-K for the fiscal year ended December 31, 2023, filed on February 21, 2024.

You may also request a copy of these filings (other than certain exhibits), at no cost, by writing or telephoning our investor relations department at the following address:

<div align='center'>Boston Scientific Corporation 
 300 Boston Scientific Way 
 Marlborough, Massachusetts 01752-1234 
 Attention: Investor Relations 
 Telephone: (508) 683-5670 
 Email: BSXInvestorRelations@bsci.com</div>

Any statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein, in any other subsequently filed document that also is or is deemed to be incorporated by reference herein or in any accompanying prospectus supplement, modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified and superseded, to constitute a part of this prospectus.

Any statement made in this prospectus concerning the contents of